" class="no-js "lang="en-US"> BostonGene - Medtech Alert
Friday, March 29, 2024
BostonGene | Pharmtech Focus

BostonGene

About BostonGene

BostonGene

BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient’s individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile. BostonGene’s mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using advanced, personalized therapies

Related Story

BostonGene and NEC Announce Global Partnership

December 15 2021

BostonGene Corporation and NEC Corporation (TSE: 6701) today announced a strategic global partnership agreement that will […]